Ryne Bio is a biotechnology company advancing off-the-shelf neuron replacement therapies as potent disease-modifying treatments for neurological disorders.

To achieve this they leverage induced pluripotent stem cell (iPSC) technology, which enables precision manufacture of therapeutically relevant human neurons.

Their lead program targeting Parkinson’s Disease is a cryopreserved iPSC dopamine neuron progenitor (RNDP-001) that can be reliably manufactured and delivered

Biotechnology

Research

Ryne Bio

Ryne Bio's headquarters in San Diego, CA, United States

Nicholas Manusos

Carter Cliff

Rajesh Mistry

Anton Bittner

Martin Ostrowski

Howard Federoff

Jeffrey Kordower

Description

People (1)

Anton Bittner

Jobs